Michigan has asked CMS for permission to enter into outcomes-based contracts with drug manufacturers under its Medicaid program, Michigan Department of Health and Human Services spokesman Bob Wheaton confirmed Monday (Oct. 15). If the request is approved, Michigan would be the second state allowed to enter into outcomes-based contracts, behind Oklahoma. Outcomes-based contracts stipulate that if patients using the medications do not meet specified benchmarks, manufacturers could be on the hook for paying additional rebates. In return, the drugs are...